NYSEAMERICAN:ATNM

Actinium Pharmaceuticals - ATNM Price Target & Analyst Ratings

$5.91

+0.21 (+3.68%)

(As of 08/12/2022 12:00 AM ET)

Add

Compare

Today's Range: $5.59
▼
$5.91
50-Day Range: N/A
52-Week Range: $4.41
▼
$10.30

Volume: 123,049 shs
Average Volume: 427,103 shs
Market Capitalization: $140.57 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $31.67

Actinium Pharmaceuticals Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$31.67
435.82% Upside

High Prediction	$45.00
Average Prediction	$31.67
Low Prediction	$25.00

Type	Current 8/12/21 to 8/12/22	1 Month Ago 7/13/21 to 7/13/22	3 Months Ago 5/14/21 to 5/14/22	1 Year Ago 8/12/20 to 8/12/21
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$31.67	$31.67	$31.67	$35.00
Predicted Upside	435.82% Upside	338.39% Upside	338.39% Upside	284.62% Upside

Get Actinium Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ATNM and its competitors with MarketBeat's FREE daily newsletter.

ATNM Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ATNM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Actinium Pharmaceuticals Stock vs. The Competition

Type	Actinium Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.71	2.50
Consensus Rating	Buy	Buy	Hold
Predicted Upside	435.82% Upside	724.39% Upside	13.81% Upside
News Sentiment Rating	Neutral News	Positive News	Neutral News
MarketBeat Community Rating	Outperform Votes 353 77.07% Underperform Votes 105 22.93%	Avg. Outperform Votes 167 66.80% Avg. Underperform Votes 83 33.20%	Avg. Outperform Votes 840 68.74% Avg. Underperform Votes 382 31.26%

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/12/2022	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	$45.00	+574.66%
10/6/2021	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy	$25.00	+205.62%
9/15/2021	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$20.00 ➝ $25.00	+266.57%
12/31/2020	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy

(Data available from 8/12/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)

ATNM Price Target - Frequently Asked Questions

What is Actinium Pharmaceuticals's consensus rating and price target?: According to the issued ratings of 3 analysts in the last year, the consensus rating for Actinium Pharmaceuticals stock is Buy based on the current 3 buy ratings for ATNM. The average twelve-month price prediction for Actinium Pharmaceuticals is $31.67 with a high price target of $45.00 and a low price target of $25.00. Learn more on ATNM's analyst rating history.
Do Wall Street analysts like Actinium Pharmaceuticals more than its competitors?: Analysts like Actinium Pharmaceuticals more than other Medical companies. The consensus rating score for Actinium Pharmaceuticals is 3.00 while the average consensus rating score for medical companies is 2.71. Learn more on how ATNM compares to other companies.
Do MarketBeat users like Actinium Pharmaceuticals more than its competitors?: MarketBeat users like Actinium Pharmaceuticals more than other Medical companies. 77.07% of MarketBeat users gave Actinium Pharmaceuticals an outperform vote while medical companies recieve an average of 66.80% outperform votes by MarketBeat users.

Does Actinium Pharmaceuticals's stock price have much upside?: According to analysts, Actinium Pharmaceuticals's stock has a predicted upside of 338.39% based on their 12-month price targets.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

This page (NYSEAMERICAN:ATNM) was last updated on 8/12/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms